Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anhui Haikang Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical manufacturer headquartered in Anqing, Anhui Province, China. Established in 2003, the company specializes in the research, development, and production of chemical active pharmaceutical ingredients (APIs) and finished dosage forms, including tablets, capsules, and granules. Its product portfolio primarily addresses therapeutic areas such as cardiovascular health, infectious diseases, and gastrointestinal disorders, with key generic offerings including amlodipine besylate and azithromycin. The company operates multiple GMP-certified production lines and is recognized as a regional high-tech enterprise. Anhui Haikang serves the domestic Chinese healthcare market while also exporting pharmaceutical intermediates to international clients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anhui HaiKang.